125 related articles for article (PubMed ID: 36538637)
1. Negative Prognostic Impact of Tumor Deposits in Rectal Cancer: A National Study Cohort.
Agger E; Jörgren F; Jöud A; Lydrup ML; Buchwald P
Ann Surg; 2023 Sep; 278(3):e526-e533. PubMed ID: 36538637
[TBL] [Abstract][Full Text] [Related]
2. Adverse impact of tumor deposits in lymph node negative rectal cancer - a national cohort study.
Lundström S; Agger E; Lydrup ML; Jörgren F; Buchwald P
Int J Colorectal Dis; 2023 Mar; 38(1):66. PubMed ID: 36897408
[TBL] [Abstract][Full Text] [Related]
3. Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
Marjasuo ST; Lehtimäki TE; Koskenvuo LE; Lepistö AH
Eur J Surg Oncol; 2024 Jun; 50(6):108337. PubMed ID: 38657373
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis.
Moon JY; Lee MR; Ha GW
Int J Colorectal Dis; 2022 Jan; 37(1):141-151. PubMed ID: 34595585
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumor deposits in rectal cancer: A monocentric series of 505 patients.
Benoit O; Svrcek M; Creavin B; Bouquot M; Challine A; Chafai N; Debove C; Voron T; Parc Y; Lefevre JH
J Surg Oncol; 2020 Dec; 122(7):1481-1489. PubMed ID: 32789859
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.
Yamai D; Shimada Y; Nakano M; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Nagai T; Ling Y; Okuda S; Watanabe G; Nogami H; Maruyama S; Takii Y; Wakai T
Int J Clin Oncol; 2023 Oct; 28(10):1388-1397. PubMed ID: 37481501
[TBL] [Abstract][Full Text] [Related]
7. Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy.
Wang Y; Zhang J; Zhou M; Yang L; Wan J; Shen L; Liang L; Yao Y; Zhang H; Zhang Z
Cancer Med; 2019 Apr; 8(4):1508-1520. PubMed ID: 30790459
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
9. Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?
Song JS; Chang HJ; Kim DY; Kim SY; Baek JY; Park JW; Park SC; Choi HS; Oh JH
Cancer; 2011 Sep; 117(17):3917-24. PubMed ID: 21858800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Extranodal Extension in Rectal Cancer Patients Undergoing Radical Resection After Preoperative Chemoradiotherapy.
Kim YI; Cho H; Kim CW; Park Y; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2021 Mar; 20(1):e35-e42. PubMed ID: 33191166
[TBL] [Abstract][Full Text] [Related]
11. Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients.
Jhuang YH; Chou YC; Lin YC; Hu JM; Pu TW; Chen CY
World J Gastroenterol; 2023 Mar; 29(11):1735-1744. PubMed ID: 37077516
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and staging value of tumor deposits in patients with rectal cancer after neoadjuvant chemoradiotherapy.
Xu T; Yu Z; Zhang Q; Liu B; Li Y; Wang F
Transl Cancer Res; 2021 Dec; 10(12):5028-5039. PubMed ID: 35116355
[TBL] [Abstract][Full Text] [Related]
13. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
Cohen R; Shi Q; Meyers J; Jin Z; Svrcek M; Fuchs C; Couture F; Kuebler P; Ciombor KK; Bendell J; De Jesus-Acosta A; Kumar P; Lewis D; Tan B; Bertagnolli MM; Philip P; Blanke C; O'Reilly EM; Shields A; Meyerhardt JA
Ann Oncol; 2021 Oct; 32(10):1267-1275. PubMed ID: 34293461
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.
Lord AC; Corr A; Chandramohan A; Hodges N; Pring E; Airo-Farulla C; Moran B; Jenkins JT; Di Fabio F; Brown G
Lancet Oncol; 2022 Jun; 23(6):793-801. PubMed ID: 35512720
[TBL] [Abstract][Full Text] [Related]
15. The value of tumor deposits in evaluating colorectal cancer survival and metastasis: a population-based retrospective cohort study.
Wu W; Zeng S; Zhang X; Liu P; Qiu T; Li S; Gong P
World J Surg Oncol; 2022 Feb; 20(1):41. PubMed ID: 35189906
[TBL] [Abstract][Full Text] [Related]
16. Tumour deposits in colon cancer predict recurrence and reduced survival in a nationwide population-based study.
Jörgren F; Agger E; Lydrup ML; Buchwald P
BJS Open; 2023 Nov; 7(6):. PubMed ID: 38035752
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of Tumor Deposit as a Prognostic Factor in Pancreatic Cancer.
Hua J; Xu J; Liang C; Meng Q; Zhang B; Yu X; Wang W; Shi S
Ann Surg Oncol; 2023 May; 30(5):3038-3044. PubMed ID: 36692614
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of Mesorectal Tumor Deposits in Patients with Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Aguilar-Romero JM; Aguilar-Romero E; Vergara-Fernández O; Zepeda-Najar C; Lino-Silva LS; Salcedo-Hernández RA
J Gastrointest Cancer; 2023 Jun; 54(2):687-691. PubMed ID: 35411420
[TBL] [Abstract][Full Text] [Related]
19. Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery.
Lieto E; Auricchio A; Ronchi A; Del Sorbo G; Panarese I; Ferraraccio F; De Vita F; Galizia G; Cardella F
J Gastrointest Surg; 2024 Jan; 28(1):47-56. PubMed ID: 38353074
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of tumor deposits on overall survival in colorectal cancer: Based on Surveillance, Epidemiology, and End Results database.
Wu WX; Zhang DK; Chen SX; Hou ZY; Sun BL; Yao L; Jie JZ
World J Gastrointest Oncol; 2022 Sep; 14(9):1699-1710. PubMed ID: 36187391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
